Walsh, Robert J.
Sundar, Raghav http://orcid.org/0000-0001-9423-1368
Lim, Joline S. J. http://orcid.org/0000-0001-8979-8597
Article History
Received: 6 January 2023
Revised: 18 January 2023
Accepted: 23 January 2023
First Online: 6 February 2023
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: RW reported serving on the advisory board of Pfizer; receiving honoraria from Pfizer outside the submitted work. RS reported serving on the advisory board of Bristol Myers Squibb, Merck, Eisai, Bayer, Taiho, Novartis, MSD, DKSH, and GSK; receiving honoraria from MSD, Eli Lilly, Bristol Myers Squibb, Roche, Taiho, AstraZeneca, Ipsen, and DKSH; and receiving grants from Roche, AstraZeneca, Taiho, Eisai, DKSH, Paxman Coolers, Natera, and MSD outside the submitted work. JL reported advisory activity with AstraZeneca, Novartis, Roche, DKSH, Pfizer and MSD; receiving honoraria from AstraZeneca, Novartis, Roche, DKSH, MSD, Eisai, Pierre Fabre; receiving research funding from CTI biopharma, Daiichi Sankyo, Synthon pharmaceuticals; and receiving a travel grant from AstraZeneca and MSD outside the submitted work.
Free to read: This content has been made available to all.